BIONTECH SE (BNTX): Price and Financial Metrics
BIONTECH SE (BNTX)
Today's Latest Price: $88.69 USD
Updated Oct 23 4:00pm
Add BNTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BNTX Stock Summary
- BNTX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.2 -- higher than merely 4.26% of US-listed equities with positive expected earnings growth.
- BNTX's went public 1.04 years ago, making it older than only 0.38% of listed US stocks we're tracking.
- BNTX's price/sales ratio is 164.88; that's higher than the P/S ratio of 97.91% of US stocks.
- Stocks that are quantitatively similar to BNTX, based on their financial statements, market capitalization, and price volatility, are MRNA, ANAB, BGNE, INCY, and ARGX.
- Visit BNTX's SEC page to see the company's official filings. To visit the company's web site, go to www.biontech.de.
BNTX Stock Price Chart Interactive Chart >
BNTX Price/Volume Stats
| Current price | $88.69 | 52-week high | $105.00 |
| Prev. close | $86.36 | 52-week low | $16.12 |
| Day low | $87.06 | Volume | 2,079,700 |
| Day high | $89.99 | Avg. volume | 1,930,016 |
| 50-day MA | $72.82 | Dividend yield | N/A |
| 200-day MA | $56.88 | Market Cap | 20.07B |
BIONTECH SE (BNTX) Company Bio
BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders.
Loading social stream, please wait...